RAYVEN
Dead / Abandoned — Abandoned — failure to respond (as of 10 Aug 2020)
What this means for you
This application is over — abandoned 27 Jul 2020. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88658332
- Mark type
- Stylized text
- Filed
- 17 Oct 2019
- Abandoned
- 27 Jul 2020
- Attorney of record
- Laurence Rickles
Goods and services
- Class 005 — Pharmaceuticals: Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines affecting the sensory organs; Pharmaceuticals and medicines affecting the central nervous system; Pharmaceuticals and medicines affecting the urogenital organs; Pharmaceuticals and medicines affecting the circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression, neuroprotective agent; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism
Owner
- Actavis Holdco US, Inc., Parsippany, NJ, US
Prosecution history
- 10 Aug 2020 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 10 Aug 2020 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 24 Jan 2020 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 24 Jan 2020 — NON-FINAL ACTION E-MAILED
- 24 Jan 2020 — NON-FINAL ACTION WRITTEN
- 23 Jan 2020 — ASSIGNED TO EXAMINER
- 22 Oct 2019 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 21 Oct 2019 — NEW APPLICATION ENTERED